You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

HBV - Liver Steatosis

Meta-analysis Shows Interferon Reduces Progression to Cirrhosis and Liver Cancer in People with Chronic Hepatitis B
4/03/09

Chronic Hepatitis B Patients May Need to Begin Liver Cancer Screening at a Younger Age than Currently Recommended
3/27/09

Frequent Liver Function Tests Can Detect Transient ALT Increases in Chronic Hepatitis B Patients
3/20/09

HBV Reactivation Leads to a High Risk of Fulminant Liver Failure and Death
9/05/08

Chronic Hepatitis B Patients with Normal or Minimally Elevated ALT and Detectable HBV DNA May Experience Active Liver Disease Progression - 6/06/08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 Google Custom Search
FDA-approved Therapies for Chronic HBV Infection
Baraclude  (entecavir)
Epivir-HBV
  (lamivudine; 3TC)
Hepsera
  (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
Viread  (tenofovir)
Tyzeka   (telbivudine)

Experimental Treatments

HBV Articles by Topic

Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation

Steatosis
Children / Infants / Women
Hepatitis B Clinical Trials
Experimental Treatments
FAQs About Hepatitis
Genotypes
Guidelines
Tests for HBV
Vaccines for HBV